Business
Allergy Therapeutics at H.C. Wainwright Conference
Allergy Therapeutics at H.C. Wainwright Conference.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n Allergy Therapeutics plc\n \n \n \n (\"\n A\n l\n l\n e\n r\n gy\n \n T\n he\n r\n a\n peu\n t\n i\n cs\", the \"Group\"\n \n or\n \n \"\n C\n o\n m\n p\n a\n n\n y\n \"\n )\n \n \n \n \n \n \n \n \n Allergy Therapeutics to Present at the H.C. Wainwright Global Investment Conference\n \n \n \n \n \n \n \n \n \n 5 September 2022\n \n Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announces that\n company management will\n participate in a fireside chat at the upcoming H.C. Wainwright Global Investment Conference being held September 12-14, 2022, in New York, NY and virtually.\n \n \n The virtual fireside chat will be available to registered attendees of the conference for on-demand viewing beginning September 12, 2022 at 9:00 a.m. ET/2:00 p.m. BST. A replay of the presentation will be made available under the 'Investors' section on Allergy Therapeutics' website at \n \n www.allergytherapeutics.com/investors/results-reports-and-presentations/\n \n .\n \n \n \n \n \n - ENDS -\n \n \n \n \n \n \n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n Allergy Therapeutics\n \n \n \n +44 (0) 1903 845 820\n \n \n Manuel Llobet, Chief Executive Officer\n \n \n Nick Wykeman, Chief Financial Officer\n \n \n \n \n \n \n Panmure Gordon (Nominated Adviser and Broker)\n \n \n \n +44 (0) 20 7886 2500\n \n \n Freddy Crossley, Emma Earl, Corporate Finance\n \n \n Rupert Dearden, Corporate Broking\n \n \n \n \n \n \n Consilium Strategic Communications\n \n \n \n +44 20 3709 5700\n \n \n Mary-Jane Elliott / David Daley / Davide Salvi\n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Stern Investor Relations, Inc.\n \n \n \n +1 212 362 1200\n \n \n Christina Tartaglia\n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n Notes for editors:\n \n \n \n \n \n \n \n \n \n About Allergy Therapeutics\n \n \n \n Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-par...